The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis
Open accessAbstract
Although liver fibrosis reflects disease severity in chronic hepatitis patients, there has been no simple and accurate system to evaluate the therapeutic effect based on fibrosis. We developed a glycan-based immunoassay, FastLec-Hepa, to fill this unmet need. FastLec-Hepa automatically detects unique fibrosis-related glyco-alteration in serum hyperglycosylated Mac-2 binding protein within 20 min. The serum FastLec-Hepa counts increased with advancing fibrosis and illustrated significant differences in medians between all fibrosis stages. FastLec-Hepa is sufficiently sensitive and quantitative to evaluate the effects of PEG-interferon-α/ribavirin therapy in a short post-therapeutic interval. The obtained fibrosis progression is equivalent to -0.30 stages/year in patients with sustained virological response, and 0.01 stages/year in relapse/nonresponders. Furthermore, long-term follow-up of the severely affected patients found hepatocellular carcinoma developed in patients after therapy whose FastLec-Hepa counts remained above a designated cutoff value. FastLec-Hepa is the only assay currently available for clinically beneficial therapy evaluation through quantitation of disease severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
Self-citationVallet-Pichard, A., Mallet, V., Nalpas, B., Verkarre, V., Nalpas, A., Dhalluin-Venier, V., Fontaine, H., & Pol, S. (2007) · Hepatology · doi:10.1002/hep.21669 · Cited by 2,077
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,826
Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y., & Poynard, T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04258-6 · Cited by 1,433
Chang, T.-T., Liaw, Y.-F., Wu, S.-S., Schiff, E., Han, K.-H., Lai, C.-L., Safadi, R., Lee, S. S., Halota, W., Goodman, Z., et al. (2010) · Hepatology · doi:10.1002/hep.23785 · Cited by 972
Shiratori, Y., Imazeki, F., Moriyama, M., Yano, M., Arakawa, Y., Yokosuka, O., Kuroki, T., Nishiguchi, S., Sata, M., Yamada, G., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00002 · Cited by 733
Lupberger, J., Zeisel, M. B., Xiao, F., Thumann, C., Fofana, I., Zona, L., Davis, C., Mee, C. J., Turek, M., Gorke, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2341 · Cited by 706
Bruno, S., Stroffolini, T., Colombo, M., Bollani, S., Benvegnù, L., Mazzella, G., Ascione, A., Santantonio, T., Piccinino, F., Andreone, P., et al. (2007) · Hepatology · doi:10.1002/hep.21492 · Cited by 604
A novel panel of blood markers to assess the degree of liver fibrosis†
Calès, P., Oberti, F., Michalak, S., Hubert‐Fouchard, I., Rousselet, M., Konaté, A., Gallois, Y., Ternisien, C., Chevailler, A., & Lunel, F. (2005) · Hepatology · doi:10.1002/hep.20935 · Cited by 560
Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling
Kuno, A., Uchiyama, N., Koseki-Kuno, S., Ebe, Y., Takashima, S., Yamada, M., & Hirabayashi, J. (2005) · Nature Methods · doi:10.1038/nmeth803 · Cited by 513
Self-citationOutcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C†,‡,§,¶
Morgan, T. R., Ghany, M. G., Kim, H.-Y., Snow, K. K., Shiffman, M. L., De Santo, J. L., Lee, W. M., Di Bisceglie, A. M., Bonkovsky, H. L., Dienstag, J. L., et al. (2010) · Hepatology · doi:10.1002/hep.23744 · Cited by 479
Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics
Callewaert, N., Vlierberghe, H. V., Hecke, A. V., Laroy, W., Delanghe, J., & Contreras, R. (2004) · Nature Medicine · doi:10.1038/nm1006 · Cited by 418
Cardoso, A.-C., Moucari, R., Figueiredo-Mendes, C., Ripault, M.-P., Giuily, N., Castelnau, C., Boyer, N., Asselah, T., Martinot-Peignoux, M., Maylin, S., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.028 · Cited by 333
Sasaki, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1606 · Cited by 245
Poynard, T., Halfon, P., Castera, L., Munteanu, M., Imbert-Bismut, F., Ratziu, V., Benhamou, Y., Bourliere, M., de Ledinghen, V., & FibroPaca Group (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.085795 · Cited by 239
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
Peng, C.-Y., Chien, R.-N., & Liaw, Y.-F. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.033 · Cited by 224
Castéra, L., Sebastiani, G., Le Bail, B., de Lédinghen, V., Couzigou, P., & Alberti, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.008 · Cited by 214
Rizzo, L., Calvaruso, V., Cacopardo, B., Alessi, N., Attanasio, M., Petta, S., Fatuzzo, F., Montineri, A., Mazzola, A., L'abbate, L., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.341 · Cited by 200
Hepatitis C pharmacogenetics: State of the art in 2010
Afdhal, N. H., McHutchison, J. G., Zeuzem, S., Mangia, A., Pawlotsky, J., Murray, J. S., Shianna, K. V., Tanaka, Y., Thomas, D. L., Booth, D. R., et al. (2010) · Hepatology · doi:10.1002/hep.24052 · Cited by 146
Self-citationComparison of Eight Diagnostic Algorithms for Liver Fibrosis in Hepatitis C
Boursier, J., de Lédinghen, V., Zarski, J., Fouchard‐Hubert, I., Gallois, Y., Oberti, F., & Calès, P. (2011) · Hepatology · doi:10.1002/hep.24654 · Cited by 126
Kuno, A., Kato, Y., Matsuda, A., Kaneko, M. K., Ito, H., Amano, K., Chiba, Y., Narimatsu, H., & Hirabayashi, J. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800308-mcp200 · Cited by 112
Self-citationAnti-fibrotic therapy: Lost in translation?
Schuppan, D., & Pinzani, M. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60008-7 · Cited by 97
Vanderschaeghe, D., Szekrényes, Á., Wenz, C., Gassmann, M. G., Naik, N., Bynum, M. A., Yin, H., Delanghe, J., Guttman, A., & Callewaert, N. (2010) · Analytical Chemistry · doi:10.1021/ac101560a · Cited by 82
Multilectin Assay for Detecting Fibrosis-Specific Glyco-Alteration by Means of Lectin Microarray
Kuno, A., Ikehara, Y., Tanaka, Y., Angata, T., Unno, S., Sogabe, M., Ozaki, H., Ito, K., Hirabayashi, J., Mizokami, M., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.151340 · Cited by 70
Self-citationThe HCV serum proteome: a search for fibrosis protein markers
Cheung, K. J., Tilleman, K., Deforce, D. L. D., Colle, I. O., & Vlierberghe, H. V. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01083.x · Cited by 69
Toward automated glycan analysis
Nishimura, S. (2011) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/b978-0-12-385520-6.00005-4 · Cited by 68
Iwasaki, Y., Takaguchi, K., Ikeda, H., Makino, Y., Araki, Y., Ando, M., Kobashi, H., Kobatake, T., Tanaka, R., Tomita, M., et al. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0956.x · Cited by 68
Ferraioli, G., Tinelli, C., Malfitano, A., Bello, B. D., Filice, G., Fìlice, C., Liver Fibrosis Study Group, Above, E., Barbarini, G., Brunetti, E., et al. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7517 · Cited by 64
Iacovazzi, P. A., Trisolini, A., Barletta, D., Elba, S., Manghisi, O. G., & Correale, M. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.155 · Cited by 44
Ito, K., Kuno, A., Ikehara, Y., Sugiyama, M., Saito, H., Aoki, Y., Matsui, T., Imamura, M., Korenaga, M., Murata, K., et al. (2012) · Hepatology · doi:10.1002/hep.25815 · Cited by 35
Self-citationKuno, A., Ikehara, Y., Tanaka, Y., Saito, K., Ito, K., Tsuruno, C., Nagai, S., Takahama, Y., Mizokami, M., Hirabayashi, J., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.05.028 · Cited by 28
Self-citationDu, D., Zhu, X., Kuno, A., Matsuda, A., Tsuruno, C., Yu, D., Zhang, Y., Ikehara, Y., Tanaka, Y., Zhang, X., et al. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.07.005 · Cited by 10
Self-citation
Cited by
Umemura, T., Joshita, S., Sekiguchi, T., Usami, Y., Shibata, S., Kimura, T., Komatsu, M., Matsumoto, A., Ota, M., & Tanaka, E. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.118 · Cited by 127
Metadata
- Authors
- Kuno, A., Ikehara, Y., Tanaka, Y., Ito, K., Matsuda, A., Sekiya, S., Hige, S., Sakamoto, M., Kage, M., Mizokami, M., & Narimatsu, H.
- Venue
- Scientific Reports
- Published
- 2013-01-15
- Volume
- 3
- Issue
- 1
- Pages
- 1065-1065
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2072443793
- Cited by
- 336
- References
- 35
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.